Affinia Therapeutics secured $40 million in Series C financing, led by New Enterprise Associates, to advance AFTX-201 for BAG3 dilated cardiomyopathy.
Amount Raised
$40 Million
Round Type
Series C
WalthamOtherBiotechnologyHealth CareresearchInvestors
Description
Affinia Therapeutics has closed a $40 million Series C financing led by New Enterprise Associates, with participation from Eli Lilly & Company and other existing investors. The funds will support IND submission and clinical activities for AFTX-201, targeting BAG3 dilated cardiomyopathy. Affinia aims to submit an Investigational New Drug application by Q4 2025 and start a Phase 1/2 trial in Q1 2026. The financing also enables further development within Affinia's gene therapy pipeline.
Quick answer
Affinia Therapeutics raised $40 Million in a Series C round, dated October 7, 2025. Investors: GV, Eli Lilly & Company, Alexandria Venture Investments, LLC, Atlas Venture, Avidity Partners, F Prime, Mass General Brigham Ventures and Perceptive Advisors. Affinia Therapeutics is based in Waltham, Massachusetts, United States.
- How much did Affinia Therapeutics raise?
- Affinia Therapeutics raised $40 Million in a Series C round on October 7, 2025.
- Who invested in Affinia Therapeutics?
- GV, Eli Lilly & Company, Alexandria Venture Investments, LLC, Atlas Venture, Avidity Partners, F Prime, Mass General Brigham Ventures and Perceptive Advisors are named as investors in this round.
- What does Affinia Therapeutics do?
- Affinia Therapeutics is pioneering a shift to a new class of rationally designed gene therapies that treat rare and prevalent diseases.
- Where is Affinia Therapeutics based and how big is it?
- Affinia Therapeutics is based in Waltham, Massachusetts, United States. Fundz records about 49 employees.
- Who are the decision-makers at Affinia Therapeutics?
- Fundz holds 2 contacts at Affinia Therapeutics, including the Chief Executive Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in research and Biotechnology around the same time
Companies in the same sectors as Affinia Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Brainstorm Cell Therapeutics raised $155K (Convertible Note) on November 6, 2025.
- Hepta raised $6.7M (Seed) on November 5, 2025.
- AAVantgarde Bio raised $141M (Series B) on November 3, 2025.
- Grail raised $325M (Post-IPO Equity) on October 20, 2025.
- Cyclana Bio raised $6.7M (Pre-Seed) on October 20, 2025.
- Faeth Therapeutics raised $25M (Funding Round) on October 20, 2025.
Who to call at Affinia Therapeutics, and when
A new round usually means Affinia Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Affinia Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Affinia Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Affinia Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Affinia Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Affinia Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.